Search Results - "von, Bahr L"

Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation by von Bahr, L., Batsis, I., Moll, G., Hägg, M., Szakos, A., Sundberg, B., Uzunel, M., Ringden, O., Le Blanc, K.

“…Mesenchymal stromal cells (MSCs) are explored as a novel treatment for a variety of medical conditions. Their fate after infusion is unclear, and long‐term…”
Get full text

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation by Mougiakakos, D, Jitschin, R, von Bahr, L, Poschke, I, Gary, R, Sundberg, B, Gerbitz, A, Ljungman, P, Le Blanc, K

“…Myeloid-derived suppressor cells (MDSCs) have emerged as a heterogeneic immunoregulatory population that can expand in response to inflammatory signals…”
Get full text

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation by von Bahr, L, Blennow, O, Alm, J, Björklund, A, Malmberg, K-J, Mougiakakos, D, Le Blanc, A, Oefner, P J, Labopin, M, Ljungman, P, Le Blanc, K

“…Vitamin D has emerged as a central player in the immune system, with its deficiency being implicated in the pathogenesis of several autoimmune diseases,…”
Get full text

Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties? by Moll, Guido, Alm, Jessica J., Davies, Lindsay C., von Bahr, Lena, Heldring, Nina, Stenbeck‐Funke, Lillemor, Hamad, Osama A., Hinsch, Robin, Ignatowicz, Lech, Locke, Matthew, Lönnies, Helena, Lambris, John D., Teramura, Yuji, Nilsson‐Ekdahl, Kristina, Nilsson, Bo, Blanc, Katarina

“…We have recently reported that therapeutic mesenchymal stromal cells (MSCs) have low engraftment and trigger the instant blood mediated inflammatory reaction…”
Get full text

Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood? by Moll, Guido, Rasmusson-Duprez, Ida, von Bahr, Lena, Connolly-Andersen, Anne-Marie, Elgue, Graciela, Funke, Lillemor, Hamad, Osama A., Lönnies, Helena, Magnusson, Peetra U., Sanchez, Javier, Teramura, Yuji, Nilsson-Ekdahl, Kristina, Ringdén, Olle, Korsgren, Olle, Nilsson, Bo, Le Blanc, Katarina

“…Multipotent mesenchymal stromal cells (MSCs) are tested in numerous clinical trials. Questions have been raised concerning fate and function of these…”
Get full text

Alterations in the Cellular Immune Compartment of Patients Treated with Third‐Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation by Jitschin, Regina, Mougiakakos, Dimitrios, Von Bahr, Lena, Völkl, Simon, Moll, Guido, Ringden, Olle, Kiessling, Rolf, Linder, Stig, Le Blanc, Katarina

“…Adoptive transfer of third‐party mesenchymal stromal cells (MSCs) has emerged as a promising tool for the treatment of steroid‐refractory graft‐versus‐host…”
Get full text

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses by Moll, Guido, Jitschin, Regina, von Bahr, Lena, Rasmusson-Duprez, Ida, Sundberg, Berit, Lönnies, Lena, Elgue, Graciela, Nilsson-Ekdahl, Kristina, Mougiakakos, Dimitrios, Lambris, John D, Ringdén, Olle, Le Blanc, Katarina, Nilsson, Bo

“…Infusion of human third-party mesenchymal stromal cells (MSCs) appears to be a promising therapy for acute graft-versus-host disease (aGvHD). To date, little…”
Get full text

Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells? by Moll, Guido, Hult, Annika, von Bahr, Lena, Alm, Jessica J, Heldring, Nina, Hamad, Osama A, Stenbeck-Funke, Lillemor, Larsson, Stella, Teramura, Yuji, Roelofs, Helene, Nilsson, Bo, Fibbe, Willem E, Olsson, Martin L, Le Blanc, Katarina

“…Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs)…”
Get full text

Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease-a gut feeling by Gavin, Caroline, Boberg, Erik, Von Bahr, Lena, Bottai, Matteo, Andrén, Anton Törnqvist, Wernerson, Annika, Davies, Lindsay C, Sugars, Rachael V, Le Blanc, Katarina

“…Acute graft-versus-host disease (aGvHD), post-allogeneic hematopoietic stem cell transplantation, is associated with high mortality rates in patients not…”
Get full text

Enhanced oral healing following local mesenchymal stromal cell therapy by Garming-Legert, Karin, Tour, Gregory, Sugars, Rachael, von Bahr, Lena, Davies, Lindsay C, Le Blanc, Katarina

Get full text

Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy by von Bahr, Lena, Sundberg, Berit, Lönnies, Lena, Sander, Birgitta, Karbach, Holger, Hägglund, Hans, Ljungman, Per, Gustafsson, Britt, Karlsson, Helen, Le Blanc, Katarina, Ringdén, Olle

“…Thirty-one patients treated with mesenchymal stromal cells (MSCs) for acute graft-versus-host disease (aGVHD) or hemorrhagic cystitis between 2002 and 2007…”
Get full text

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation by Mougiakakos, D, Jitschin, R, von Bahr, L, Poschke, I, Gary, R, Sundberg, B, Gerbitz, A, Ljungman, P, Le Blanc, K

Get full text

Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy by Boberg, E, von, Bahr L, Afram, G, Lindstrom, C, Ljungman, P, Heldring, N, Petzelbauer, P, Legert, KG, Kadri, N, Le, Blanc K

Get full text

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation by Tobiasson, Magnus, Pandzic, Tatjana, Illman, Johanna, Nilsson, Lars, Weström, Simone, Ejerblad, Elisabeth, Olesen, Gitte, Björklund, Andreas, Olsnes Kittang, Astrid, Werlenius, Olle, Lorentz, Fryderyk, Rasmussen, Bengt, Cammenga, Jörg, Weber, Duruta, Lindholm, Carolin, Wiggh, Joel, Dimitriou, Marios, Moen, Ann Elin, Yip Lundström, Laimei, von Bahr, Lena, Baltzer-Sollander, Karin, Jädersten, Martin, Kytölä, Soili, Walldin, Gunilla, Ljungman, Per, Groenbaek, Kirsten, Mielke, Stephan, Jacobsen, Sten Eirik W, Ebeling, Freja, Cavelier, Lucia, Smidstrup Friis, Lone, Dybedal, Ingunn, Hellström-Lindberg, Eva

“…Clinical relapse is the major threat for patients with myelodysplastic syndrome (MDS) undergoing hematopoietic stem-cell transplantation (HSCT). Early…”
Get full text

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS by Lindholm, C., Tobiasson, M., Pandzic, T., Illman, J., Nilsson, L., Weström, S., Ejerblad, E., Olesen, G., Björklund, A., Kittang, A. Olsnes, Werlenius, O., Wiggh, J., Lorentz, F., Rasmussen, B., Cammenga, J., Weber, D., Moen, A.E., Lundström, L.Y., Bahr, L. Von, Dimitriou, M., Kytölä, S., Walldin, G., Ljungman, P., Groenbaek, K., Mielke, S., Jacobsen, S.E., Ebeling, F., Cavelier, L., Friis, L. Smidstrup, Dybedal, I., Hellstrom-Lindberg, E.

Get full text

Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study by Boberg, Erik, Bahr, Lena, Afram, Gabriel, Lindström, Carina, Ljungman, Per, Heldring, Nina, Petzelbauer, Peter, Garming Legert, Karin, Kadri, Nadir, Le Blanc, Katarina

“…Steroid‐refractory chronic graft‐vs‐host disease (cGvHD) contributes to morbidity after allogeneic hematopoietic stem cell transplantation. Here, we report on…”
Get full text

Motor impairments in children with epilepsy treated with carbamazepine by Braathen, G, von Bahr, L, Theorell, K

“…Nineteen children with epilepsy were tested on two occasions, first during treatment with carbamazepine (CBZ) and then 6 months later without treatment. Plasma…”
Get full text

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study by Von Bahr, Lena, Davies, Lindsay, Afram, Gabriel, Modin, Carina, Garming-Legert, Karin, Hägglund, Hans, Ljungman, Per T., Le Blanc, Katarina

“…Introduction Chronic graft-versus-host disease (cGvHD) is major cause of late morbidity and mortality after allogeneic hematopoietic stem cell transplantation,…”
Get full text

COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROWAND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS by Lindholm, C, Tobiasson, M, Pandzic, T, Illman, J, Nilsson, L, Westrom, S, Ejerblad, E, Olesen, G, Bjorklund, A, Kittang, AO, Werlenius, O, Wiggh, J, Lorentz, F, Rasmussen, B, Cammenga, J, Weber, D, Moen, AE, Lundstrom, LY, Von Bahr, L, Dimitriou, M, Kytola, S, Walldin, G, Ljungman, P, Groenbaek, K, Mielke, S, Jacobsen, SE, Ebeling, F, Cavelier, L, Friis, LS, Dybedal, I, Hellstrom-Lindberg, E

Get full text

Immunosuppressive CD14 super(+)HLA-DR super(low/neg) IDO super(+) myeloid cells in patients following allogeneic hematopoietic stem cell transplantation by Mougiakakos, D, Jitschin, R, von Bahr, L, Poschke, I, Gary, R, Sundberg, B, Gerbitz, A, Ljungman, P, Le Blanc, K

“…Myeloid-derived suppressor cells (MDSCs) have emerged as a heterogeneic immunoregulatory population that can expand in response to inflammatory signals…”
Get full text